Last reviewed · How we verify
AU409
At a glance
| Generic name | AU409 |
|---|---|
| Sponsor | Lee's Pharmaceutical Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease (PHASE1)
- Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AU409 CI brief — competitive landscape report
- AU409 updates RSS · CI watch RSS
- Lee's Pharmaceutical Limited portfolio CI